[Federal Register Volume 67, Number 18 (Monday, January 28, 2002)]
[Notices]
[Pages 3900-3901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1960]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-15-02]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503. Written 
comments should be received within 30 days of this notice.
    Proposed Project: Pilot Study of the U.S. Action Plan for 
Laboratory Containment of Wild Polioviruses--New--National Vaccine 
Program Office (NVPO), Centers for Disease Control and

[[Page 3901]]

Prevention (CDC). Global polio eradication is anticipated within the 
next few years. The only sources of wild polio virus will be in 
biomedical laboratories. Prevention of inadvertent transmission of 
polio viruses from the laboratory to the community is crucial.
    The first step toward prevention is a national survey of all 
biomedical laboratories. The survey will alert laboratories to the 
impending eradication of polio, encourage the disposition of all 
unneeded wild polio virus infectious and potentially infectious 
materials, and establish a national inventory of laboratories retaining 
such materials. Laboratories on the inventory will be kept informed of 
polio eradication progress and notified, when necessary, to implement 
bio-safety requirements appropriate for the risk of working with such 
materials.
    An estimated 15,000 biomedical laboratories, in six categories of 
institutions: Academic, federal government, hospital, industry, 
private, and state and local government facilities, will be included in 
the final survey. We propose conducting pilot studies in 525 biomedical 
laboratories representing the above six categories. Specific survey 
strategies for each category will be refined through these pilot 
surveys. Three types of biomedical laboratories within each 
institutional category will be targeted by the pilot survey: Those most 
likely to possess wild polio virus materials; those least likely to 
possess wild polio virus materials; and those that may possess wild 
polio virus materials.
    The survey instruments will ask laboratories to indicate whether or 
not they possess wild polio virus infectious and/or potentially 
infectious materials. If such materials are present, respondents are 
asked to indicate the types of materials and estimated numbers 
retained. Survey instruments will be available on the NVPO web page, 
and institutions will be encouraged to submit completed survey forms 
electronically. The total burden for this data collection is 350 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                                  Average burden/
                           Respondents                               Number of      Responses/     response  (in
                                                                    respondents     respondent        hours)
----------------------------------------------------------------------------------------------------------------
Labs most likely to possess.....................................             175               1           30/60
Labs least likely to possess....................................             175               1           30/60
Labs that may possess...........................................             175               1           60/60
----------------------------------------------------------------------------------------------------------------


    Dated: January 18, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-1960 Filed 1-25-02; 8:45 am]
BILLING CODE 4163-18-P